Wordt geladen...
BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma
BACKGROUND: Nonfunctioning pituitary adenoma (NFPA) and growth hormone pituitary adenoma (GHPA) are major subtypes of pituitary adenomas (PAs). The primary treatment is surgical resection. However, radical excision remains challenging, and few effective medical therapies are available. It is urgent...
Bewaard in:
| Gepubliceerd in: | Neuro Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7594556/ https://ncbi.nlm.nih.gov/pubmed/32246150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa084 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|